CLEARWATER, Fla., May 06, 2026 (GLOBE NEWSWIRE) -- via IBN -- MedWell Ai, Inc, (OTCQB:MWAI) ("Company") is a portfolio company, specializing in AI-driven solutions for B2B markets in pharmaceuticals, healthcare, and wellness sectors, is pleased to confirm the filing, of its Quarterly Report (Form 10-Q), for the financial period, ending on March 31, 2026.

Key Financial Highlights:

Increased Total Revenues:

For three months, ended March 31, 2026, Company had generated total revenues of $618,676 ($638,336 including deferred revenues) vs $281,318, for three months, ended March 31, 2025.

For nine months, ended March 31, 2026, Company had generated total revenues of $1,694,482 vs $425,327, for nine months, ended March 31, 2025.

The Company reconfirms yearly revenue guidance of $2.3 million.

Reduced Total Loss From Operations:

For three months, ended March 31, 2026, Company's net loss was reduced to $227,939 from $814,192, for three months, ended March 31, 2025.

For nine months, ended March 31, 2026, Company's net loss was reduced to $827,961 from $1,718,272, for nine months, ended March 31, 2025.

Reduced General And Administrative Expenses:

For three months, ended March 31, 2026, Company's expenses were reduced to $364,539 from $1,129,360, for ...